突变全小鼠胚胎的单细胞 RNA 测序:从上胚层到原肠胚形成结束
June 14th, 2024
1.9K views
本文建立了用于单细胞和细胞核测序的高质量原肠胚单细胞和细胞核悬液的管道。
我们专注于破译胚胎干细胞分化过程中控制早期细胞命运决策的机制，无论是在体外还是在小鼠模型中。复杂的调控网络指导发育过程中的分化，我们研究了信号通路、转录因子和表观遗传调节因子的相互作用如何促进不同的细胞命运。研究小鼠原肠胚形成的动态和快速过程在技术上具有挑战性，因为每个胚胎的细胞数量较少，而且每窝具有所需基因型的胚胎数量有限。
虽然文献广泛表明使用野生型或荧光激活细胞分选胚胎群对单细胞进行研究，但对具有谱系突变的胚胎的全面分析仍然有限。我们的协议提供了从携带谱系突变的原纤维胚胎生成单细胞组学数据集的可能性。它将帮助没有或有限的小鼠处理经验或想要学习早期胚胎操作或单细胞方法的科学家。
我们的方案将有助于回答原肠胚形成和早期器官发生（包括心脏发育）中的新科学问题。我们提供了一个以单细胞分辨率分析谱系特异性突变胚胎的管道，这将有助于分析特定基因在谱系定型中的作用。我们希望使用这种方法来了解原肠胚形成快速动态过程中细胞命运决定的调控机制。
概述
本研究提出了一种从胚胎发育期的小鼠胚胎中获得高质量单细胞和细胞核悬液的协议。这种方法促进了单细胞和细胞核的测序，使得对胚胎发育的全面分析成为可能。
关键研究组成部分
科学领域
- 神经科学
- 发育生物学
- 遗传学
背景
- 胚胎发生是胚胎发育的关键阶段。
- 早期细胞命运决定受复杂调控网络的影响。
- 关于具有谱系突变的胚胎的研究有限。
- 由于每个胚胎中的细胞数量较少，单细胞分析具有挑战性。
研究目的
- 建立一个可靠的胚胎发生期小鼠胚胎单细胞分析的协议。
- 使经验有限的研究人员能够进行胚胎操作。
- 促进具有谱系突变的胚胎的组学数据集的生成。
使用的方法
- 从小鼠胚胎中分离单细胞和细胞核。
- 单细胞和细胞核悬液的测序。
- 将该协议应用于具有特定遗传背景的胚胎。
- 分析胚胎发生期间的信号通路和转录因子。
主要结果
- 该协议成功生成了高质量的单细胞悬液。
- 它允许对早期细胞命运决定进行全面分析。
- 促进了对具有谱系突变的胚胎的研究。
- 为新手研究人员提供了一个宝贵的胚胎操作资源。
结论
- 本研究为研究小鼠胚胎发生提供了一种新颖的方法。
- 建立的协议增强了对胚胎发育的理解。
- 为在胚胎模型中研究谱系突变开辟了新的研究途径。
常见问题
什么是胚胎发生？
胚胎发生是胚胎发育的一个阶段，单层的胚泡重组成多层结构。
为什么单细胞分析很重要？
单细胞分析使研究人员能够理解细胞群体的异质性和细胞分化的机制。
研究胚胎发生有哪些挑战？
每个胚胎中细胞数量少和具有所需基因型的胚胎的有限供应使其在技术上具有挑战性。
这个协议如何使研究人员受益？
它提供了一种简单的方法来生成单细胞数据集，特别是对于那些在胚胎操作方面经验有限的人。
什么是谱系突变？
谱系突变是影响胚胎发生过程中特定细胞谱系的发育命运的遗传改变。
这个协议可以应用于其他物种吗？
虽然这个协议是为小鼠胚胎设计的，但类似的技术可能通过适当的修改被应用于其他物种。
Executive Industry Relevance
Single-cell RNA sequencing of mutant mouse embryos during gastrulation enables unprecedented resolution of cell fate decisions and lineage specification, directly informing early discovery and target validation in developmental biology and disease modeling. This robust pipeline overcomes technical barriers in genotyping and cell viability, supporting predictive confidence in mechanistic studies of gene function. The approach enhances portfolio value by enabling systematic interrogation of genetic perturbations at critical developmental inflection points.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables high-resolution mapping of gene expression dynamics during lineage commitment.
- Supports functional validation of genetic targets implicated in early organogenesis.
- Facilitates mechanistic de-risking by linking mutations to cellular phenotypes at single-cell resolution.
- Improves predictive confidence for target selection in developmental and regenerative medicine pipelines.
Screening & Assay Development
- Provides validated single-cell and nuclei suspensions for downstream omics workflows.
- Standardizes sample preparation and genotyping for reproducible quantitative outputs.
- Enables scalable screening of genetic perturbations in synchronized embryonic populations.
- Supports robust assay development for evaluating gene function in complex tissues.
Translational & Preclinical Research
- Aligns cellular phenotypes with disease-relevant developmental stages for translational biomarker discovery.
- Ensures continuity from early discovery through preclinical validation of gene function.
- De-risks advancement decisions by providing mechanistic insight into developmental defects.
- Enables modeling of congenital disease mechanisms at the single-cell level.
Pipeline & Workflow Integration
This methodology integrates from early discovery through lead identification and preclinical research, enabling systematic analysis of gene function during embryogenesis.
- Discovery Biology: Supports hypothesis testing and pathway clarification by resolving cell state transitions in mutant embryos.
- Screening: Delivers reproducible, quantitative single-cell data for comparative analysis of genetic variants.
- Analytics: Provides high-content readouts for statistical comparison of cell populations and gene expression profiles.
- Translational Research: Bridges discovery and preclinical stages by modeling disease-relevant developmental processes.
- Enterprise Reuse: Establishes a standardized, reusable workflow for single-cell analysis of diverse genetic models.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in target validation.
- Operational Value: Enhances standardization, reproducibility, and scalability of single-cell workflows.
- Strategic Value: Improves go/no-go decisions and capital efficiency by enabling early de-risking of genetic targets.
- Portfolio Impact: Supports risk-adjusted prioritization and advancement of developmental biology programs.
Implementation Considerations
- Requires expertise in embryology, single-cell genomics, and genotyping protocols.
- Demands access to microfluidic partitioning platforms and high-throughput sequencing infrastructure.
- Necessitates rigorous cross-team standardization for sample handling and data analysis.
- Adaptation may be needed for different developmental stages or genetic backgrounds.
- Cell yield and viability are constrained by embryo stage and genotype frequency.
Biopharma FAQs
Why does null hypothesis testing matter for single-cell mutant embryo analysis?
Null hypothesis testing enables objective evaluation of whether observed gene expression changes in mutant embryos are statistically significant, supporting robust target validation and reducing false positives in early discovery.
How does independent variable isolation fit the genotyping and embryo pooling workflow?
Isolating embryos by genotype ensures that downstream single-cell analyses attribute cellular phenotypes to specific genetic perturbations, increasing mechanistic clarity and predictive value for R&D decisions.
What do quantitative dependent variable measurements enable in single-cell RNA-seq of gastrulating embryos?
Quantitative single-cell measurements allow precise comparison of gene expression and cell state distributions across genotypes, enabling detection of subtle lineage effects and supporting data-driven prioritization of targets.
Why are replication requirements critical for cross-functional collaboration in this pipeline?
Replication across embryos and litters ensures reproducibility and reliability of findings, facilitating data integration and interpretation by multidisciplinary teams in discovery and translational research.
What statistical analysis capabilities are required before implementing single-cell mutant embryo sequencing?
Robust statistical tools are needed to analyze high-dimensional single-cell data, control for batch effects, and validate genotype-phenotype associations, ensuring actionable insights for portfolio advancement.
